Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
HHS has released an implementation plan on specific actions for entities to take in preventing and treating sexually transmitted infections (STI).News Article updated on 06/13/2023
-
Health Centers on the Front Lines Podcast: Status Neutral
Review of concept of status neutral (access to HIV services regardless of HIV status).Resource updated 10/24/2023
-
Addressing STIs: Ask. Test. Treat. Repeat.
Nine sites implemented four evidence-based interventions, collectively known as Addressing STIs: Ask.Test.Treat.Repeat. The four intervention components are audio computer-assisted self-interview sexual history taking, patient self-collection of urogenital and extragenital site chlamydia/gonorrhea nucleic acid amplification test specimens, sexual and gender minority welcoming indicators, and provider training, with the overall goal to routinize STI screening, testing, and treatment in primary care. The interventions increased routine STI screening and testing of bacterial STIs based on reported behavioral risk.Resource from the RWHAP Best Practices Compilation updated on 05/14/2024
-
What Can We Do to Improve Equity? A Debate
What clinics can do to improve health equity.Resource updated 08/17/2023
-
CQII Eliminating Disparities Due to Substance Use Issues - Core Interventions
Core interventions related to addressing substance use in order to eliminate disparities in viral suppression rates.Resource updated 09/14/2023
-
Input Sought on Federal HIV Research Priorities
The NIH Office of AIDS Research (OAR) leads the effort across NIH to establish HIV research priorities and develop the NIH Strategic Plan for HIV and HIV-Related Research.News Article updated on 02/15/2024 -
Virginia Rapid Start Collaborative
Virginia Rapid Start launched with HIV care providers across the state with goals to initiate ART for clients within 14 days of HIV diagnosis and to improve access to, and retention in, high-quality HIV care and support services. Through Virginia Rapid Start, providers initiated ART medications within an average of four days of HIV diagnosis, as compared with the statewide average of 28 days. Virginia Rapid Start clients had higher rates of viral suppression compared to both the RWHAP Part B overall and Virginia overall. The success of Virginia Rapid Start led VDH to expand the program to the entire Virginia RWHAP Part B.Resource from the RWHAP Best Practices Compilation updated on 01/18/2024
-
Funding Opportunity: RWHAP Implementation for HIV Clinical Quality Improvement (HRSA-24-072)
This HRSA HIV/AIDS Bureau pre-application webinar was for the Notice of Funding Opportunity, Ryan White HIV/AIDS Program (RWHAP) Implementation for HIV Clinical Quality Improvement (HRSA-24-072).Resource updated 01/29/2024
-
Huntridge Rapid Start Initiative
The Huntridge Family Clinic launched the Rapid Start Initiative to provide same-day ART treatment and comprehensive case management to clients with a new diagnosis of HIV. Over 90% of clients received ART on the same day as diagnosis, and 78% of clients were retained in care within the first year of starting treatment.Resource from the RWHAP Best Practices Compilation updated on 01/08/2024
-
Positive Care Center Rapid Access
Positive Care Center implemented the Rapid Access program in 2018, providing clients with ART on the same day as HIV diagnosis. Pharmacists, embedded within Positive Care Center’s care team, help clients with their treatment plans and adherence strategies. Over 90% of clients served through Rapid Access in 2021 received ART on the same day as diagnosis, and 82% of clients were retained in care at six months.Resource from the RWHAP Best Practices Compilation updated on 01/12/2024
-
Innovative HIV Care Strategies to Address HIV and STIs
This webinar features Addressing STIs: Ask. Test. Treat. Repeat., an intervention for people with HIV or those who are vulnerable to HIV acquisition.Resource updated 05/15/2024
-
Replicating Innovative HIV Care Strategies in the RWHAP
Webinar series featuring HIV care innovations developed under HRSA SPNS projects.Resource updated 04/02/2024
-
JumpstART
JumpstART launched in 2016 as part of New York State’s Ending the Epidemic initiative, changing the service delivery model of eight sexual health clinics to include an initial prescription of ART after an HIV diagnosis and prior to linkage to the community provider. Between November 2016 and September 2018, 60% of JumpstART clients received ART on the same day as diagnosis. JumpstART clients were also more likely to reach viral suppression within three months compared to non-JumpstART clients.Resource from the RWHAP Best Practices Compilation updated on 12/15/2023
-
Recap of Viral Suppression Improvements Under Impact Now Collaborative
CQII hosted a virtual Learning Session for our Impact Now Collaborative participants on February 6 and 7, 2024.News Article updated on 05/09/2024 -
Is Medicare About to Cover PrEP Under Part B?
Is Medicare going to adopt the practice of private health insurance and start covering PrEP without cost-sharing under Part B?News Article updated on 05/14/2024 -
Data Webinar Q&A Summaries
This page is a collection of all the written Q&A summary documents from webinars co-hosted by the DISQ Team and RWHAP Data Support. If you have any additional questions about the content covered here, please contact DISQ via our TA Request Form or DISQ email account.
Resource updated 06/05/2024
-
2024 National HIV Testing Day Theme Announcement
The National HIV Testing Day theme for 2024 is “Level up your self-love: check your status.”News Article updated on 05/28/2024 -
HIV Prevention and Care Improvements Summarized in CDC Surveillance Reports
In the U.S., the number of new HIV cases continue to decline, most people are linked to care within one month of their HIV diagnosis, and 69% reach viral suppression within 6 months of HIV diagnosis.News Article updated on 06/10/2024 -
Doxy PEP Guidelines Issued by CDC
CDC has issued the first-ever guidelines recommending use of doxy PEP (doxycycline postexposure prophylaxis) for the prevention of STIs among select populations.News Article updated on 06/06/2024 -
Clinical Info HIV.gov
U.S. HIV-related treatment guidelines, drug database, and glossary.
Resource updated 09/20/2023